pyridoxine has been researched along with Raynaud Disease in 2 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ROBERT D'ESHOUGUES, J | 1 |
GILLE, C | 1 |
BIANCHI, M | 1 |
DELACROIX, J | 1 |
Kim, M | 1 |
2 other studies available for pyridoxine and Raynaud Disease
Article | Year |
---|---|
[Pyridoxin in the treatment of Raynaud's disease].
Topics: Humans; Pyridoxine; Raynaud Disease; Vitamin B 6 | 1962 |
[Drugs in syndromes of dysfunction of arteriovenous anastomoses].
Topics: Acetylcholine; Animals; Arteriovenous Anastomosis; Epinephrine; Ergoloid Mesylates; Histamine; Human | 1967 |